
Sign up to save your podcasts
Or


Pepsi’s 3rd quarter was strong thanks to Frito-Lay. TD Ameritrade rises on reports it may buy out rival Scottrade. And Medtronic gets FDA approval for an artificial pancreas. Plus we dip into the Fool Mailbag with Bill Mann and Bryan Hinmon from Motley Fool Funds. Thanks to Pearl Auto for supporting this episode. Go to http://PearlAuto.com/Fool to get free 2-day shipping!
By The Motley Fool4.7
16041,604 ratings
Pepsi’s 3rd quarter was strong thanks to Frito-Lay. TD Ameritrade rises on reports it may buy out rival Scottrade. And Medtronic gets FDA approval for an artificial pancreas. Plus we dip into the Fool Mailbag with Bill Mann and Bryan Hinmon from Motley Fool Funds. Thanks to Pearl Auto for supporting this episode. Go to http://PearlAuto.com/Fool to get free 2-day shipping!

3,241 Listeners

1,501 Listeners

806 Listeners

944 Listeners

529 Listeners

1,189 Listeners

2,185 Listeners

825 Listeners

1,426 Listeners

1,053 Listeners

9,716 Listeners

194 Listeners

827 Listeners

83 Listeners

50 Listeners

1,034 Listeners

50 Listeners